Evidence map›Paper›PMID 24595187›Full record

ArticlePloS one2014

The burden of musculoskeletal conditions.

Clémence Palazzo, Jean-François Ravaud, Agathe Papelard, Philippe Ravaud, Serge Poiraudeau

5 registry-linked trialsAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Cited by 94 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04264481 nacompletednot on this mapstarted 2019, after this paper: background citation

Minimally Invasive Knee Osteoarthritis Pain Control Via Adductor Canal Block Versus Intra-articular Steroid and Lignocaine Injection : a Single-blinded Controlled Trial

TypeinterventionalSponsorUniversity of MalayaRan2019 to 2020Enrolled64ConditionsKnee OsteoarthritisArmsAdductor Canal Block, Intra-Articular Steroid and Lignocaine Injection
NCT04765787 completednot on this mapstarted 2020, after this paper: background citation

Clinical Response of Nuberol Forte® for the Pain Management in Musculoskeletal Disorders in Routine Pakistani Practice

TypeobservationalSponsorThe Searle Company Limited PakistanRan2020 to 2021Enrolled399ConditionsMusculoskeletal Disorder, Pain ManagementArmsCombination of Paracetamol 650mg + Orphenadrine 50mg
NCT05286333 completednot on this mapstarted 2022, after this paper: background citation

Identification of Risk Factors for Recurrence of Low Back Pain and Occupational Repercussions Among Beneficiaries of a Multidisciplinary Follow-up Shared Between Physical and Rehabilitation Medicine and Occupational Medicine: a Monocentric Prospective Study

TypeobservationalSponsorFondation IldysRan2022 to 2026Enrolled51ConditionsLow Back Pain
NCT06628466 completednot on this mapstarted 2022, after this paper: background citation

Clinical Response of Nuberol Forte in Chronic Neck Pain in Routine Rehabilitation Centers

Typeobservational_patient_registrySponsorThe Searle Company Limited PakistanRan2022 to 2024Enrolled150ConditionsChronic Neck PainArmsNuberol Forte
NCT07736248 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Super Selective Angiographic Catheterization and Embolization of Genicular Arteries for Treatment of Symptomatic Knee Osteoarthritis

TypeinterventionalSponsorAssiut UniversityRan2026 to 2028Enrolled30ConditionsAngioembolization in Knee OsteoarthritisArmsgenicular artery embolization, Calibrated microspheres (100-300 µm), Microcatheter
3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Clémence PalazzoU1153, Institut National de la Santé et de la Recherche Médicale, Paris, France; Centre d'Épidémiologie Clinique, Hôpital Hôtel Dieu AP-HP, Paris, France; Université Paris Descartes, PRES Sorbonne Paris Cité, Paris, France; Service de rééducation et réadaptation de l'appareil locomoteur et des pathologies du rachis, Hôpital Cochin AP-HP, Paris, France.
Jean-François RavaudInstitut fédératif de recherche sur le handicap, Institut National de la Santé et de la Recherche Médicale, Paris, France; U988, Institut National de la Santé et de la Recherche Médicale, Villejuif, France; UMR 8211, Centre national de la recherche scientifique, Villejuif, France.
Agathe PapelardService de rééducation et réadaptation de l'appareil locomoteur et des pathologies du rachis, Hôpital Cochin AP-HP, Paris, France; Institut fédératif de recherche sur le handicap, Institut National de la Santé et de la Recherche Médicale, Paris, France.
Philippe RavaudU1153, Institut National de la Santé et de la Recherche Médicale, Paris, France; Centre d'Épidémiologie Clinique, Hôpital Hôtel Dieu AP-HP, Paris, France; Université Paris Descartes, PRES Sorbonne Paris Cité, Paris, France.
Serge PoiraudeauU1153, Institut National de la Santé et de la Recherche Médicale, Paris, France; Université Paris Descartes, PRES Sorbonne Paris Cité, Paris, France; Service de rééducation et réadaptation de l'appareil locomoteur et des pathologies du rachis, Hôpital Cochin AP-HP, Paris, France; Institut fédératif de recherche sur le handicap, Institut National de la Santé et de la Recherche Médicale, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDespite the burden of rheumatic and musculoskeletal diseases (RMDs), these conditions probably deserve more attention from public health authorities in several countries including developed ones. We assessed their contribution to disability.

methodsData on disabilities associated with RMDs were extracted from the national 2008-2009 Disability-Health Survey of 29,931 subjects representative of the population in France. We used the core set of disability categories for RMDs of the World Health Organization's International Classification of Functioning, Disability and Health for analysis. Diagnosis and disabilities were self-reported. We assessed the risk of disability associated with RMDs using odds ratios (ORs) and the societal impact of RMDs using the average attributable fraction (AAF).

resultsOverall 27.7% (about 17.3 million people) (95% CI 26.9-28.4%) of the population reported having RMDs. The most prevalent RMDs were low back pain (12.5%, 12.1-13.1) and osteoarthritis (12.3%, 11.8-12.7). People reporting osteoarthritis were more disabled in walking (adjusted OR 1.9, 1.7-2.2) than those without. People reporting inflammatory arthritis were more limited in activities of daily living (from 1.4, 1.2-1.8 for walking to 2.1, 1.5-2.9 for moving around). From a societal perspective, osteoarthritis was the main contributor to activity limitations (AAF 22% for walking difficulties). Changing jobs was mainly attributed to neck pain (AAF 13%) and low back pain (11.5%).

conclusionRMDs are highly prevalent and significantly affect activity limitations and participation restrictions. More effort is needed to improve care and research in this field.

Indexed as

Activities of Daily LivingAdultAgedArthritisDisability EvaluationFemaleFranceHealth SurveysHumansLow Back PainMaleMiddle AgedMobility LimitationMusculoskeletal DiseasesWalking

Identifiers

PMID24595187
PMCPMC3942474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.